乳腺MRI影像组学预测Ki-67表达
本研究回顾性纳入154例患者159个乳腺病灶,从增强T1加权MRI和ADC图提取影像组学特征,以14%和20%两个Ki-67截断值分类,发现基于ADC图的影像组学特征结合广义线性模型可能无创判断Ki-67表达水平。
要点
- ADC图影像组学在Ki-67截断值14%时测试集AUC为0.849,表现较好。
- Ki-67截断值20%时各序列模型测试集AUC均未超过0.75。
- ADC图联合增强T1序列未显著提升测试集分类性能。
诊断标准与关键数值
- Ki-67截断值14%时,ADC图训练集AUC 0.785(SD 0.193)、测试集AUC 0.849;增强T1训练集AUC 0.696(SD 0.150)、测试集AUC 0.695;两序列联合训练集AUC 0.755(SD 0.171)、测试集AUC 0.635。
- Ki-67截断值20%时,ADC图训练集AUC 0.744(SD 0.197)、测试集AUC 0.617;增强T1训练集AUC 0.629(SD 0.251)、测试集AUC 0.741;两序列联合训练集AUC 0.761(SD 0.207)、测试集AUC 0.618。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: We aimed to investigate the value of magnetic resonance image (MRI)-based radiomics in predicting Ki-67 expression of breast cancer.
METHODS: In this retrospective study, 159 lesions from 154 patients were included. Radiomic features were extracted from contrast-enhanced T1-weighted MRI (C+MRI) and apparent diffusion coefficient (ADC) maps, with open-source software. Dimension reduction was done with reliability analysis, collinearity analysis, and feature selection. Two different Ki-67 expression cut-off values (14% vs 20%) were studied as reference standard for the classifications. Input for the models were radiomic features from individual MRI sequences or their combination. Classifications were performed using a generalized linear model.
RESULTS: Considering Ki-67 cut-off value of 14%, training and testing AUC values were 0.785 (standard deviation [SD], 0.193) and 0.849 for ADC; 0.696 (SD, 0.150) and 0.695 for C+MRI; 0.755 (SD, 0.171) and 0.635 for the combination of both sequences, respectively. Regarding Ki-67 cut-off value of 20%, training and testing AUC values were 0.744 (SD, 0.197) and 0.617 for ADC; 0.629 (SD, 0.251) and 0.741 for C+MRI; 0.761 (SD, 0.207) and 0.618 for the combination of both sequences, respectively.
CONCLUSION: ADC map-based selected radiomic features coupled with generalized linear modeling might be a promising non-invasive method to determine the Ki-67 expression level of breast cancer.
引用
- Kayadibi Y, Kocak B, Ucar N, et al. Radioproteomics in Breast Cancer: Prediction of Ki-67 Expression With MRI-based Radiomic Models. Acad Radiol. 2021. PMID: 33744071. doi:10.1016/j.acra.2021.02.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。